Header Image
News Room / Biotechnology

Biotechnology

RSS Feed

Rosetta Genomics Expands Patent Protection for Thyroid microRNA Biomarkers with U.S. Patent Allowance
11/13/2017 -- 8:00 AM -- Rosetta Genomics Ltd.

Molecular Partners Expands and Advances Robust Pipeline of DARPin(R) Therapies in Oncology and Ophthalmology
11/9/2017 -- 1:00 AM -- Molecular Partners AG

Rosetta Genomics Receives NASDAQ Notification
11/8/2017 -- 8:00 AM -- Rosetta Genomics Ltd.

MorphoSys Announces Presentation of Clinical Data on Proprietary Blood Cancer Compound MOR208 at Upcoming American Society of Hematology Annual Meeting 2017
11/2/2017 -- 3:15 AM -- MorphoSys AG

Shareholders of Molecular Partners Approved the Elections of Bill Burns and Patrick Amstutz to the Board of Directors
10/31/2017 -- 11:45 AM -- Molecular Partners AG

Dr. Markus Enzelberger Appointed MorphoSys's Chief Scientific Officer
10/30/2017 -- 7:05 AM -- MorphoSys AG

MorphoSys to Host Q3 2017 Conference Call on November 7, 2017
10/26/2017 -- 8:20 AM -- MorphoSys AG

INTERIM MANAGEMENT STATEMENT Q3 2017: Significant Progress Across All Clinical Programs - New Pre-clinical Immuno-oncology Data to be Presented During R&D Day in New York
10/26/2017 -- 1:00 AM -- Molecular Partners AG

MorphoSys Receives FDA Breakthrough Therapy Designation for Its Antibody MOR208 in Relapsed/Refractory DLBCL
10/23/2017 -- 5:06 PM -- MorphoSys AG

Favorable Data from Independent Study Comparing RosettaGX Reveal(TM) versus Afirma(R) to Accurately Classify Indeterminate Thyroid Nodules Were Presented at the 87th Annual Meeting of the American Thyroid Association
10/23/2017 -- 9:00 AM -- Rosetta Genomics Ltd.

Qrons Announces Signing of Option Agreement with Dartmouth College
10/20/2017 -- 7:00 AM -- Qrons Inc.

Modern Mobility Aids Unveils New Business Model: Investments in Cryptocurrency, Gaming, and E-Wallet
10/18/2017 -- 7:00 AM -- Modern Mobility Aids, Inc.

Rosetta Genomics Expands Patent Estate for Thyroid Cancer Detection microRNA Biomarkers with U.S. Patent Allowance
10/17/2017 -- 8:00 AM -- Rosetta Genomics Ltd.

RosettaGX Reveal to be Highlighted in Poster Presentations at the 87th Annual Meeting of the American Thyroid Association
10/16/2017 -- 8:00 AM -- Rosetta Genomics Ltd.

Rosetta Genomics and MediNcrease Health Plans Announce Provider Agreement Expanding Access to RosettaGX(TM) Reveal and Other Testing Services
10/12/2017 -- 9:15 AM -- Rosetta Genomics Ltd.

First Patient Dosed in Phase 1 Clinical Study of Molecular Partners’ Second Proprietary Oncology Asset MP0274
10/12/2017 -- 1:00 AM -- Molecular Partners AG

Top